Navigation Links
Pfizer Hemophilia presents new data at the World Federation of Hemophilia 2010 Congress
Date:7/8/2010

BUENOS AIRES, ARGENTINA, July 9 Pfizer Inc, the world's leading biopharmaceutical company, today announced that the results of a number of hemophilia studies will be presented at the World Federation of Hemophilia (WFH) 2010 Congress taking place July 10-14, 2010, in Buenos Aires, Argentina. Key research includes a pre-clinical evaluation of recombinant factor Xa as a potential new approach to restoring hemostasis, as well as a study assessing the potential for an engineered recombinant factor VIIa molecule to improve therapeutic outcomes in mouse models of hemophilia. These presentations follow Pfizer's recent announcement about the creation of a new research unit focused on rare diseases, including hemophilia.

"We are very excited to present these data, which highlights the strength of our pipeline and our enduring commitment to provide recombinant products for the hemophilia community," says Brenda Cooperstone, M.D., vice president of clinical development and medical affairs for the Specialty Care Business Unit at Pfizer. "Our investigation of novel therapies for hemophilia treatment remains ongoing and we will continue to work closely with our partnersincluding the World Federation of Hemophiliato help improve hemophilia care worldwide."

Early Research with Factor Xa and VIIa

Pfizer will present the results of a pre-clinical study in mice indicating that recombinant factor Xa therapy may provide a unique way to bypass deficiencies in the intrinsic pathway. Additional results from a preclinical study in mice suggest that a recombinant factor VIIa molecule with increased activity and duration of action may have the potential to improve inhibitor outcomes.

Additional Hemophilia Research from Pfizer at WFH

  • New model of antibody-induced hemophilia A for the assessment of bypass therapies
  • An electronic documentation system in Haemophilia provides otherwise unavailable feedback for continuous qua
    '/>"/>

Contact: Gwen Fisher
Gwen.Fisher@Pfizer.com
484-865-5160
Edelman Public Relations
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Pfizer joins open-access medicinal chemistry public-private collaboration
2. VIDEO from Medialink and National Fibromyalgia Association and Pfizer Inc.: The Science Behind Fibromyalgia
3. Sigma-Aldrich Reaches Agreement to Sell Pfizers Bioactive Small Molecule Compounds
4. Arizona Myeloma Network presents Special Award to TGen president
5. ItsHot.com Presents Aesthetic Diamond Jewelry and Diamond Watches at Wholesale Prices
6. Morehead Presents Webinar on “Managing the Paradox of Employee Alignment and Engagement”
7. RockWest Technology Group Presents Campus Contactless Card Technology at NACCU
8. NextAid Presents BIDS BUILD HOPE Online Auction to Benefit Projects on the Ground in Africa on World AIDS Orphans Day
9. Morehead Presents Webinar on “Creating a High-Performing RN Workforce”
10. AllianceDiamonds.com Presents: Facebook Diamond Giveaway 2010
11. Aderans Research Presents at SID (Society of Investigative Dermatology)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2015)... ... 2015 , ... Targeted therapies, made possible by a growing ... according to a newly published report. Surviving Mesothelioma has more on the findings ... The authors of the new paper focus on several types of targeted approaches ...
(Date:8/29/2015)... (PRWEB) , ... August 29, 2015 , ... Brands like ... with zero standard shipping costs. , “Before, a threshold of $49.00 was required ... select brands and items qualify for free standard shipping for customers regardless of the ...
(Date:8/29/2015)... Aliso Viejo, CA (PRWEB) , ... August 29, 2015 , ... ... Cut Pro X . Each preset contains 15 seconds of unique footage that users ... presets that rise, fall, zoom, attract and more. Users can customize color, brightness, scale, ...
(Date:8/29/2015)... ... August 29, 2015 , ... ... the localized area with stretching, soft tissue manipulation. Platelet rich plasma injections also ... shown through research to improve treatment outcomes. This localized treatment seems to ...
(Date:8/29/2015)... ... 29, 2015 , ... Vascular Health Sciences announced today that ... Arterosil HP, and that all claims and counterclaims have been irrevocably dismissed. , ... in the United States District Court for the Southern District of Texas for ...
Breaking Medicine News(10 mins):Health News:Top Mesothelioma Researchers Highlight Targeted Therapies in New Report, According to Surviving Mesothelioma 2Health News:TheBeautyPlace.com Discounts Shipping on Select Brands 2Health News:FCPX Effects Developer, Pixel Film Studios, Releases ProDrop Particles. 2Health News:NEW APPROACH for Treatment of Recurrent Hamstring Strains and Hamstring Tendinosis is Available for the First Time in NYC 2Health News:NEW APPROACH for Treatment of Recurrent Hamstring Strains and Hamstring Tendinosis is Available for the First Time in NYC 3
... Human Settlement Programme, UN-Habitat and cola giant Coca Cola ... to safe drinking water and improved sanitation in India ... ,The project in India will be implemented in West ... non-government organisations (NGOs), the scheme aims at introducing rain ...
... and faculty of Indian origin add to the rich ethnic ... 430 km from here, where a gunman went on a ... of Indian origin. ,Founded in 1872, the Virginia ... called, has more than 25,000 students from as many as ...
... to sign an agreement with the International Vaccine Institute (IVI) ... has given its assent to the move. ,The ... country would now be able to play a role in ... ,The IVI is an International Organization established at the ...
... breast-feeding can negate the risks of breast cancer which are ... of 25. ,The findings of the study ... at the 2007 annual meeting of the American Association for ... may have a protective effect that negates the increased risk ...
... and appearing in today's advance online publication of Nature ... new tool for studying disease mechanisms and for identifying ... disease. ,Both studies were completed by researchers ... Estess Laboratory for Stem Cell Research, the world's first ...
... on arthritis, yet another study says. It neither prevents or ... studies. // ,"We do not have evidence to suggest ... says author Peter Jüni, head of clinical epidemiology and biostatistics ... paper comes a little more than a year after a ...
Cached Medicine News:Health News:Campaign for Safe Drinking Water in India, Nepal 2Health News:Indians Add to Rich Diversity of Virginia Tech 2Health News:Breastfeeding Keeps Breast Cancer At Bay- For Older Mothers 2Health News:Stem Cells Provide New Tool for Studying Disease and Identifying ALS Drugs 2Health News:Chondroitin may Not Have Any Beneficial Effect on Arthritis, New Study Says 2Health News:Chondroitin may Not Have Any Beneficial Effect on Arthritis, New Study Says 3
(Date:8/28/2015)... , Aug. 28, 2015 ... announced the addition of the "Investigation Report ... their offering. Originally discovered by Welfide ... Pharmaceutical Industries, Ltd) as an inflammatory drug, pranoprofen ... Pharmaceutical Co., Ltd under the trade name of ...
(Date:8/28/2015)... Utah , Aug. 28, 2015  Today, in ... Prevention,s (CDC) Contact Lens Health Week, 1-800 Contacts is ... has found that contact lens wearers who do not ... greatest risk for eye infections. Most ... their lenses, but a clean lens case is sometimes ...
(Date:8/28/2015)... Aug. 28, 2015 ... the addition of the "Investigation Report on ... offering. Developed by Pharmacia & Upjohn ... agonist which effectively reduces intraocular pressure. As the ... (under the trade name of Xalatan) entered ...
Breaking Medicine Technology:Investigation Report on China's Pranoprofen Market, 2010-2019 21-800 Contacts Shares Tips on How to Clean Lens Cases 2China Latanoprost Market Investigation Report 2015-2019 2
... FRANKLIN, Tenn., April 13, 2011 In the Journal ... March issue, a comparative research evaluation of five needleless I.V. ... InVision-Plus® (RYM-5001®) zero displacement connector best protected the intraluminal pathway ... The purpose of the study was to evaluate ...
... 12, 2011 Digital Assent founder ... this year,s "Top Up-and-Coming Entrepreneur" award, which will be presented ... from TiE Atlanta, an organization whose mission is to foster ... 2009 Ibbotson founded Digital Assent and launched its flagship product ...
Cached Medicine Technology:According to the Journal of Advanced Nursing, RyMed Technologies' InVision-Plus® Excels at Minimizing Bacterial Growth In Vitro 2Digital Assent CEO Selected as Finalist for 2011 Southeast Entrepreneur Awards 2
... Single Use linear stapler with LACTOMER™ ... Suture™ PREMIUM POLY CS™-57 disposable surgical ... of a temporary opening, such as ... section, or when transecting muscle tissue, ...
... Units With Titanium Staples for ... (Single Use Reloadable Stapler with ... Suture™ PREMIUM MULTIFIRE TA™ stapler ... pediatric and thoracic surgical procedures ...
... Single Use Loading Units for ... (Single Use Reloadable Staplers with ... Suture™ TA™ Reloadable staplers has ... and thoracic surgical procedures for ...
... linear stapler for resection, transection and anastomosis ... MULTIFIRE GIA™ 60 and 80 single use ... 80 single use loading units and the ... use surgical stapler with MULTIFIRE SGIA™ 60 ...
Medicine Products: